iSAEC
Originally published Aug. 9.
ISAEC Launches New Study in IBD; Completes Enrollment in Hypersensitivity, Liver Toxicity Trials
NEW YORK (GenomeWeb News) – The International Serious Adverse Events Consortium has finished enrolling two studies investigating genetic markers linked to drug-induced liver injury and hypersensitivity reactions, and it has launched a new study focused on finding markers of treatment-related inf
ISAEC Launches Consortium Focused on Genetics Research into Drug-induced Renal Injury
NEW YORK (GenomeWeb News) – The International Serious Adverse Events Consortium today said that it will collaborate with scientists at the University of California, San Diego School of Medicine and UC San Diego Skaggs School of Pharmacy on research into the genetics behind drug-induced renal inju
iSAEC Partners with Catholic Health Initiatives
The International Severe Adverse Event Consortium will collaborate with CHI's Center for Translational Research to identify genetic markers for adverse drug reactions.
SAEC Partners with Shanghai University to Explore Ethnic Variation in Adverse Drug Reactions
Premium
The iSAEC this week announced a partnership with Shanghai Jaio Tong University to study serious drug reactions in Chinese populations, expanding the group's understanding of the impact of ethnic diversity on genomically influenced adverse events with a strong immunological underpinning.
May 4, 2011
McGill, iSAEC Partner on TB Drug Reactions
Feb 2, 2011
Oct 19, 2010
Sep 30, 2010
SAEC Names New Partners, Launches Stage II
Feb 3, 2010
Oct 21, 2009